company background image
NVNO logo

enVVeno Medical NasdaqCM:NVNO Stock Report

Last Price

US$3.41

Market Cap

US$59.8m

7D

4.0%

1Y

-10.3%

Updated

24 Nov, 2024

Data

Company Financials +

enVVeno Medical Corporation

NasdaqCM:NVNO Stock Report

Market Cap: US$59.8m

NVNO Stock Overview

A clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. More details

NVNO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

enVVeno Medical Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for enVVeno Medical
Historical stock prices
Current Share PriceUS$3.41
52 Week HighUS$6.97
52 Week LowUS$3.01
Beta1.22
11 Month Change2.71%
3 Month Change-38.22%
1 Year Change-10.26%
33 Year Change-52.64%
5 Year Change-72.46%
Change since IPO-97.40%

Recent News & Updates

Recent updates

Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation

Jun 26
Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation

Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth

Mar 07
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth

Will enVVeno Medical (NASDAQ:NVNO) Spend Its Cash Wisely?

Aug 14
Will enVVeno Medical (NASDAQ:NVNO) Spend Its Cash Wisely?

Is enVVeno Medical (NASDAQ:NVNO) In A Good Position To Deliver On Growth Plans?

Apr 22
Is enVVeno Medical (NASDAQ:NVNO) In A Good Position To Deliver On Growth Plans?

We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate

Dec 21
We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate

enVVeno Medical: Unique Exposure To Venous Treatment Domain

Sep 23

We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely

Aug 23
We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely

enVVeno Medical reports Q2 results

Aug 03

We Think enVVeno Medical (NASDAQ:NVNO) Can Afford To Drive Business Growth

May 10
We Think enVVeno Medical (NASDAQ:NVNO) Can Afford To Drive Business Growth

We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate

Jan 25
We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate

Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics

Sep 08

Hancock Jaffe Laboratories finance chief sheds interim tag

Dec 31

Hancock Jaffe approves 1:25 reverse stock split

Nov 27

Shareholder Returns

NVNOUS Medical EquipmentUS Market
7D4.0%1.5%2.2%
1Y-10.3%20.8%31.6%

Return vs Industry: NVNO underperformed the US Medical Equipment industry which returned 20.9% over the past year.

Return vs Market: NVNO underperformed the US Market which returned 31.7% over the past year.

Price Volatility

Is NVNO's price volatile compared to industry and market?
NVNO volatility
NVNO Average Weekly Movement10.4%
Medical Equipment Industry Average Movement8.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: NVNO's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: NVNO's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
199931Robert Bermanwww.envveno.com

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company’s lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI.

enVVeno Medical Corporation Fundamentals Summary

How do enVVeno Medical's earnings and revenue compare to its market cap?
NVNO fundamental statistics
Market capUS$59.80m
Earnings (TTM)-US$21.24m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NVNO income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$21.24m
Earnings-US$21.24m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.21
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did NVNO perform over the long term?

See historical performance and comparison